Compare EVER & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVER | CTKB |
|---|---|---|
| Founded | 2008 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 571.6M | 595.2M |
| IPO Year | 2018 | 2021 |
| Metric | EVER | CTKB |
|---|---|---|
| Price | $17.47 | $3.35 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $27.00 | $5.63 |
| AVG Volume (30 Days) | ★ 1.2M | 694.4K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 198.86 | N/A |
| EPS | ★ 0.51 | N/A |
| Revenue | $163,349,000.00 | ★ $193,015,000.00 |
| Revenue This Year | $14.73 | $5.42 |
| Revenue Next Year | $11.51 | $7.03 |
| P/E Ratio | $36.65 | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $13.88 | $2.37 |
| 52 Week High | $28.73 | $6.18 |
| Indicator | EVER | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 48.97 | 25.20 |
| Support Level | $14.40 | $3.28 |
| Resistance Level | $26.09 | $4.26 |
| Average True Range (ATR) | 1.55 | 0.27 |
| MACD | 0.08 | -0.13 |
| Stochastic Oscillator | 33.39 | 0.00 |
EverQuote Inc operates an online marketplace for insurance shopping, connecting consumers with insurance providers, including carriers and agents. Its marketplace is powered by proprietary data and technology platform that delivers high-intent, pre-validated consumer referrals aligned with insurers underwriting and profitability requirements. The platform provides transparency and campaign management tools, enabling providers to evaluate marketing spend performance and manage return on investment. Consumers can visit insurance provider websites, engage by phone, or submit data to receive quotes. Services are free for consumers, and the company derives revenue principally from consumer inquiries sold as referrals to insurance providers. It derives a majority of revenue from Direct channels.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.